Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 3
2007 6
2008 10
2009 9
2010 5
2011 7
2012 10
2013 8
2014 9
2015 10
2016 6
2017 10
2018 7
2019 12
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
Stone JH, et al. N Engl J Med 2010 - Clinical Trial. PMID 20647199 Free PMC article.
RESULTS: Nine centers enrolled 197 ANCA-positive patients with either Wegener's granulomatosis or microscopic polyangiitis. Baseline disease activity, organ involvement, and the proportion of patients with relapsing disease were similar in the two treatment groups. ...
RESULTS: Nine centers enrolled 197 ANCA-positive patients with either Wegener's granulomatosis or microscopic polyangiitis. Baseline …
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement
Geetha D, et al. J Am Soc Nephrol 2015 - Clinical Trial. PMID 25381429 Free PMC article.
Complete remission (CR) was defined as Birmingham Vasculitis Activity Score/Wegener's Granulomatosis (BVAS/WG)=0 off prednisone. ...
Complete remission (CR) was defined as Birmingham Vasculitis Activity Score/Wegener's Granulomatosis (BVAS/WG)=0 off prednisone. ...
95 results
Jump to page
Feedback